Align Technology | ALGN - Cost Of Sales

Stock Price
187.60
Daily Change
11.98 6.82%
Monthly
12.46%
Yearly
-10.90%
Q1 Forecast
158.01

Align Technology reported $363.97M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
3M USD 4.08B 283M Dec/2025
Align Technology USD 363.97M 7.48M Dec/2025
Becton, Dickinson and Co. USD 5.19B 2.32B Sep/2025
Bruker USD 481.1M 41.6M Sep/2025
Cardinal Health USD 63.36B 1.57B Dec/2025
Charles River Laboratories USD 693.46M 20.52M Sep/2025
Cooper Companies USD 464.2M 45.9M Sep/2025
CVS Health USD 89.07B 3.74B Sep/2025
Danaher USD 2.87B 342M Dec/2025
Dentsply International USD 463M 17M Sep/2025
Dexcom USD 477.9M 9.6M Sep/2025
Henry Schein USD 2.38B 93M Sep/2025
Idexx Laboratories USD 432.46M 10.58M Dec/2025
Insulet USD 196.2M 700K Sep/2025
Integra LifeSciences USD 195.07M 11.2M Sep/2025
IQVIA Holdings USD 3.24B 518M Dec/2025
Masimo USD 140.9M 3.3M Sep/2025
McKesson USD 102.47B 2.86B Dec/2025
Mettler Toledo International USD 473.97M 33.71M Dec/2025
Revvity USD 324.34M 3.38M Sep/2025
Solventum Corp USD 963M 23M Sep/2025
Stryker USD 2.69B 373M Dec/2025
Teleflex USD 461.38M 111.57M Sep/2025
Thermo Fisher Scientific USD 7.58B 674M Dec/2025
Veeva Systems USD 199.46M 4.21M Sep/2025
Waters USD 327.81M 5.5M Sep/2025
Zimmer Biomet Holdings USD 735.8M 17M Sep/2025
Zoetis USD 683M 3M Sep/2025